NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Quest Diagnostics announced that it plans to sell its HemoCue diagnostic products business, as part of the company's strategy to refocus on diagnostic information services. HemoCue develops, produces ...

MADISON, N.J. (AP) -- Medical laboratory operator Quest Diagnostics Inc. said Wednesday it plans to sell its HemoCue diagnostic products unit, which makes blood and urine tests. Quest has announced ...

Following the divestment of its OralDNA Labs salivary-diagnostics business to Access Genetics in Dec 2012, leading diagnostic testing company, Quest Diagnostics (DGX), came up with the plan to sell ...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic products ...

Radiometer Limited, a leading provider of technologically advanced acute care testing solutions, is pleased to announce that following its recent acquisition of HemoCue, the Company will be offering ...

Co announces it has acquired HemoCue, a Swedish co specializing in near patient testing, also known as point-of- care testing, from the private equity firm E.Q.T II B.V. in a cash transaction valued ...

Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...